RS
RaySearch Laboratories AB (publ)
RSLBF · OTC
$19.81 +0.00% (+$0.00)
Market Cap 6.44B kr
P/E Ratio 30.30x
Div. Yield 2.19%
ROE 22.83%
Bulios Fair Price
$20.13
1.6% upside
Current Price
$19.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RSLBF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
39 /100
Fair PEG 2.37x
P/E 30.30x
P/B 8.24x
Growth
88 /100
Growing FCF growth 8.25%
EPS growth 112.81%
Book val. growth 14.45%
Profitability
94 /100
Strong Op. margin 20.30%
Gross margin 82.12%
FCF margin 22.36%
Quality
87 /100
Excellent ROA 11.81%
ROIC 16.00%
Asset turnover 0.70x
Debt
90 /100
Low Int. coverage 49.97x
Debt/Equity 0.46x
Net debt/EBITDA 0.35x
Stability
62 /100
Moderate EPS volatility 117.12%
Beta 1.00x
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RSLBF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Johan Lof
Employees
433
Headquarters
Stockholm
Upcoming events
03 NOV
Earnings
Upcoming earnings report